Who owns BridgeBio Pharma, Inc. (BBI)? Elite investor 13F holders

6 tracked elite investors reported holding BridgeBio Pharma, Inc as of 2026-09-30, including Viking Global Investors, D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

6 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or transthyretin-mediated amyloidosis (ATTR-CM); Fosdenopterin, an intravenous formulation of synthetic cyclic…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Viking Global InvestorsBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-16 00:00:00644328010.00 USD9792219.000000SharesreduceOriginal filing
D.E. ShawBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-16 00:00:00146285902.00 USD2223190.000000SharesreduceOriginal filing
Renaissance Technologies LLCBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-12 00:00:0056360727.00 USD856546.000000SharesreduceOriginal filing
Bridgewater AssociatesBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-16 00:00:0045772980.00 USD695638.000000SharesaddOriginal filing
D.E. ShawBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-16 00:00:007527268.00 USD5000000.000000PrincipalbuyOriginal filing
Gotham Asset ManagementBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-16 00:00:00457244.00 USD6949.000000SharesbuyOriginal filing
Polen Capital ManagementBRIDGEBIO PHARMA INCSHARE2026-09-302026-11-13 00:00:00296758.00 USD4510.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown